Dr James A Gideon, MD in Bluffton, OH - Internal Medicine

Dr James A Gideon, MD is a Internal Medicine - Rheumatology physician based in Bluffton, Ohio. Dr James A Gideon is licensed to practice in Ohio (license number 35.075051) and his current practice location is 139 Garau St, Bluffton, Ohio. He can be reached at his office (for appointments etc.) via phone at (419) 369-2190.

NPI number for Dr James A Gideon is 1962460485 and his current mailing address is 139 Garau St, Bluffton, Ohio. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1962460485.

Contact Information

	Dr James A Gideon, MD
	139 Garau St, Bluffton, OH 45817-1027
	(419) 369-2190
	(419) 369-4431

Physician's Profile

Full Name	Dr James A Gideon
Gender	Male
Speciality	Internal Medicine - Rheumatology
Location	139 Garau St, Bluffton, Ohio
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1962460485
Provider Enumeration Date: 05/03/2006
Last Update Date: 10/08/2013

Medical Identifiers

Medical identifiers for Dr James A Gideon such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1962460485	NPI	-	NPPES
2338787	Medicaid	OH

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RR0500X	Internal Medicine - Rheumatology	35.075051 (Ohio)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr James A Gideon is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr James A Gideon, MD 139 Garau St, Bluffton, OH 45817-1027 Ph: (419) 369-2190	Dr James A Gideon, MD 139 Garau St, Bluffton, OH 45817-1027 Ph: (419) 369-2190

News Archive

Alere makes additional open market purchases of Axis-Shield shares

Alere Inc., a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it has made additional open market purchases of 2,091,764 shares of Axis-Shield stock, bringing its total current ownership position to 3,204,995 shares, or approximately 6.4%, of Axis-Shield's issued and outstanding ordinary share capital.

Provectus Pharmaceuticals publishes article on novel treatment for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled "A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

Treating high-risk heart patients with a single, high dose of radiation therapy can dramatically reduce episodes of rapid, abnormal heartbeats for more than two years, offering hope to patients who have exhausted other treatment options.

Mediterranean diet may have benefits for cognitive functioning in later life

People who eat a Mediterranean-style diet-particularly one rich in green leafy vegetables and low in meat-are more likely to stay mentally sharp in later life, a study shows.

Dr James A Gideon, MD - Internal Medicine in Bluffton, OH